Jazz Pharmaceuticals Said to Explore Options Including Sale
- Company speaking with advisers to gauge potential interest
- Health-care sector a bright spot for dealmakers in 2023
This article is for subscribers only.
Jazz Pharmaceuticals Plc is exploring strategic options including a potential sale, people with knowledge of the matter said.
The company is speaking with advisers to help field interest, said the people, who asked not to be identified because the information is private. Jazz Pharma is also studying possibilities that might include a breakup or divestment of parts of the business, the people said.